Novo Nordisk India Pvt Ltd
Insulin Aspart (100iu)
Fiasp 100IU/ml Penfill (3ml Each) is a fast-acting type of insulin used for blood sugar control in people with type 1 and type 2 diabetes mellitus.
Solution for Injection
Fiasp 100IU/ml Penfill (3ml Each) is normally prescribed along with a long-acting type of insulin or other diabetes medicines. Your doctor or nurse will teach you the correct way of injecting it under the skin. It should be taken at the start of a meal or within 20 minutes after starting a meal. Check your blood sugar levels regularly, keep track of your results, and share them with your doctor. This is very important to work out the correct dose of the medicine for you.
Your doctor or nurse will guide you how to use this medicine.
Hypoglycemia (low blood sugar level) is a common side effect. Monitor your blood sugar level regularly. Allergies at the injection site like redness, swelling, or hard lumps (lipodystrophy). Some people gain weight while taking insulin.
It is unsafe to consume alcohol with Fiasp 100IU/ml Penfill (3ml Each).
Fiasp 100IU/ml Penfill (3ml Each) is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Fiasp 100IU/ml Penfill (3ml Each) is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Amiloride Beclometasone Betamethasone Chlorthalidone
Fiasp 100IU/ml Penfill (3ml Each) is fast-acting insulin. It starts working within 10-20 minutes after injection. It works like your body's natural insulin. Insulin facilitates reuptake of glucose in muscles and fat cells and also blocks the release of glucose from the liver.
Always carry some sugary food or fruit juice with you in case you experience hypoglycemia symptoms such as cold sweats, cool pale skin, tremors, weakness, and anxiety. Injection below the skin of the abdomen results in faster absorption than other injection sites. Injection sites must be rotated to prevent hard lumps from developing at one site.